Cite
HARVARD Citation
Shepard, G. et al. (2017). A Phase II Study with Lead‐In Safety Cohort of 5‐Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2‐Positive Esophagogastric Adenocarcinomas. Oncologist. pp. 1152-e98. [Online].